|
시장보고서
상품코드
1908766
아유르베다 시장 규모, 점유율 및 동향 분석 보고서 : 형태별, 용도별, 적응증별, 유통 채널별, 최종 용도별, 지역별, 부문별 예측(2026-2033년)Ayurveda Market Size, Share & Trends Analysis Report By Form (Herbal, Mineral, Herbomineral), By Application (Medical/Therapy, Personal), By Indication, By Distribution Channel, By End Use, By Region, And Segment Forecasts, 2026 - 2033 |
||||||
아유르베다 시장 요약
세계의 아유르베다 시장 규모는 2025년에 204억 2,000만 달러로 평가되었고, 2033년까지 858억 3,000만 달러에 이를 것으로 예측됩니다.
또한, 2026-2033년에는 CAGR 19.72%를 나타낼 것으로 예측됩니다. 이러한 성장은 주로 만성 질환 증가, 아유르베다의 효능에 대한 인식 증가, 그리고 전체 소비자층에서 아유르베다의 강력한 채택과 수용에 기인합니다.
님, 강황, 백단향 등 아유르베다 원료를 사용한 유기농 및 천연 퍼스널케어 제품에 대한 수요 증가도 업계 성장을 견인하고 있습니다. 주요 시장 동향으로는 아유르베다 보충제의 건강 효능을 입증하는 임상연구를 들 수 있습니다. 이는 과학적 근거를 강화하고, 소비자의 신뢰를 높이며, 시장 보급을 촉진하고 있습니다. 아유르베다 의약품과 치료법은 서양의학에 비해 부작용이 적다는 점에서도 지지받고 있습니다. 예를 들어, 2024년 9월부터 10월까지 'Journal of Research in Ayurvedic Sciences'지에 게재된 논문에 따르면, 수세기에 걸친 경험적 아유르베다를 실험적, 임상적, 관찰적, 계통적 검토, 메타분석과 같은 엄격한 과학적 방법을 통해 재평가해야 한다고 설명합니다. 재평가해야 한다고 설명되어 있습니다. 저자들은 이 접근법을 통해 건선, 고혈압, 비만, 당뇨병, 근골격계 질환 등에 효과적으로 대처할 수 있다고 지적합니다.
예를 들어, 강황은 항염증 효과가 연구로 입증되어 다양한 건강보조식품에 널리 사용되고 있습니다. 코로나19 팬데믹 기간 동안 예방 건강관리 및 면역력 향상 제품에 대한 소비자의 관심이 높아지면서 시장 수요가 급증했습니다. 락다운과 사회적 거리두기 조치로 인해 소비자의 행동은 아유르베다 보충제 및 의약품을 포함한 유기농 및 천연 제품으로 옮겨갔습니다. 또한, 스트레스와 불안 수준 관리에 대한 아유르베다의 효능에 대한 인식이 높아진 것도 코로나19 기간 동안 시장 성장에 기여했습니다. 세계 각국 정부는 아유르베다의 잠재적 효능을 인식하고 그 사용을 규제하고 촉진하는 조치를 취하고 있습니다.
예를 들어, 인도에서는 전통의학 및 대체의학 체계의 진흥을 목적으로 AYUSH 부처가 설치되어 있습니다. 상업정보통계총국(DGCI&S)에 따르면 인도의 아유르베다 및 허브 제품 수출액은 2021년(FY21) 4억 7,960만 달러에서 2023년(FY23)에는 6억 6,200만 달러로 증가할 것으로 예측됩니다. 한편, 인도의 아유르베다 및 허브 제품 수입액도 2021년도(FY21) 7,140만 달러(590억 7,000만 루피)에서 2023년(FY23) 9,110만 달러(753억 8,000만 루피)로 증가하여 CAGR 13%를 나타낼 것으로 예측됩니다. 그 결과 인도의 아유르베다 및 허브 제품 무역 흑자 규모는 2021년도(4억 8,200만 달러/337억 6,700만 루피)에서 2023년(5억 1,510만 달러/42억 6,500만 루피)으로 증가했습니다.
자주 묻는 질문
목차
제1장 조사 방법과 범위
제2장 주요 요약
제3장 아유르베다 시장 변수, 동향 및 범위
- 시장 계통 전망
- 상위 시장 전망
- 관련·부수 시장 전망
- 시장 역학
- 아유르베다 시장 분석 툴
- 업계 분석 : Porter's Five Forces
- PESTEL 분석
제4장 아유르베다 시장 : 형태별 추정 및 동향 분석
- 형태별 시장 점유율(2025-2033년)
- 아유르베다 시장 : 형태별 전망
- 시장 규모와 예측 및 동향 분석(2021-2033년)
- 허브
- 미네랄
- 허브 미네랄
제5장 아유르베다 시장 : 용도별 추정 및 동향 분석
- 용도별 시장 점유율(2025-2033년)
- 아유르베다 시장 : 용도별 전망
- 시장 규모와 예측 및 동향 분석(2021-2033년)
- 의료 및 치료
- 퍼스널케어
제6장 아유르베다 시장 : 적응증별 추정 및 동향 분석
- 적응증별 시장 점유율(2025-2033년)
- 아유르베다 시장 : 적응증별 전망
- 시장 규모와 예측 및 동향 분석(2021-2033년)
- 소화기계 질환
- 감염증
- 피부 및 모발
- 호흡기
- 신경계
- 순환기계
- 생식기계
- 기타
제7장 아유르베다 시장 : 유통 채널별 추정 및 동향 분석
- 유통 채널별 시장 점유율(2025-2033년)
- 아유르베다 시장 : 유통 채널별 전망
- 시장 규모와 예측 및 동향 분석(2021-2033년)
- 직접 판매
- 전자상거래
- 소매 및 기관용 판매
제8장 아유르베다 시장 : 최종 용도별 추정 및 동향 분석
- 최종 용도별 시장 점유율(2025-2033년)
- 아유르베다 시장 : 최종 용도별 전망
- 시장 규모와 예측 및 동향 분석(2021-2033년)
- 병원 및 진료소
- 재택 환경
제9장 아유르베다 시장 : 지역별 분석
- 아유르베다 : 시장 점유율 분석, 2025-2033년
- 아유르베다 : 지역별 시장 추산 및 예측
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
제10장 경쟁 구도
- 주요 시장 진출기업별 최근 동향과 영향 분석
- 기업/경쟁 분류
- 벤더 구도
- 주요 유통업체 및 채널 파트너 리스트
- Key customers
- Key company heat map analysis, 2025
- 기업 개요
- Kerala Ayurveda Ltd.
- Patanjali Ayurved Limited
- Dabur Ltd.
- Natreon Inc.
- Vicco Laboratories
- Himalaya Wellness Company
- Emami Group of Companies Pvt Ltd.
- Bio Veda Action Research Co.
- Amrutanjan Health Care Limited
- Baidyanath
Ayurveda Market Summary
The global ayurveda market size was valued at USD 20.42 billion in 2025 and is expected to reach USD 85.83 billion by 2033, growing at a CAGR of 19.72% from 2026 to 2033. This growth is largely due to the rising prevalence of chronic diseases, increasing awareness of Ayurvedic benefits, and strong adoption and acceptance of Ayurveda across consumer groups.
Growing demand for organic and natural personal care products that use Ayurvedic ingredients such as neem, turmeric and sandalwood is also strengthening industry expansion. A key market trend involves clinical studies that highlight the health benefits of Ayurvedic supplements, which have increased scientific validation, boosted consumer trust and supported wider market uptake. Ayurvedic medicines and treatments are further preferred for their comparatively lower side effects than allopathy. For instance, from September to October 2024, the Journal of Research in Ayurvedic Sciences published an editorial explaining that centuries of empirical Ayurveda should be reassessed using rigorous scientific methods, including experimental, clinical, observational, systematic review and meta-analysis designs. The authors noted that this approach could help address psoriasis, hypertension, obesity, diabetes and musculoskeletal disorders more effectively.
For instance, Turmeric is widely used in various supplements due to its anti-inflammatory properties, which have been validated by research. The market witnessed a surge in demand due to the increasing consumer focus on preventive healthcare and immunity-boosting products during the COVID-19 pandemic. The lockdowns and social distancing measures led to a shift in consumer behavior towards natural and organic products, including Ayurvedic supplements and medicines. Moreover, the growing awareness about the benefits of Ayurveda in managing stress and anxiety levels also contributed to the market growth during COVID-19. Governments around the world are recognizing the potential benefits of Ayurveda and are taking steps to regulate and promote its use.
For instance, in India, the Ministry of AYUSH (Ayurveda, Yoga & Naturopathy, Unani, Siddha, and Homeopathy) has been established to promote traditional medicine and alternative medicine systems. According to the Directorate General of Commercial Intelligence and Statistics (DGCI&S), India's exports of Ayurvedic and herbal products have increased from USD 479.6 million (3,967.4 crores INR) in FY21 to USD 606.2 million (5,014.3 crores INR) in FY23. On the other hand, the import of Ayurvedic and herbal products in India has also increased USD 71.4 million (590.7 crores INR) in FY21 to USD 91.1 million (753.8 crores INR) in FY23, with a compound annual growth rate of 13 %. As a result, India's trade surplus in Ayurvedic and herbal products increased from 408.2 million (3,376.7 crore INR) in FY21 to USD 515.1 million (4,260.5 crore INR) in FY23.
Global Ayurveda Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033s. For this study, Grand View Research has segmented the global Ayurveda market report based on form, application, indications, distribution channel, end use, and region:
- Form Outlook (Revenue, USD Million, 2021 - 2033)
- Herbal
- Mineral
- Herbomineral
- Application Outlook (Revenue, USD Million, 2021 - 2033)
- Medical/Therapy
- Personal
- Indications Outlook (Revenue, USD Million, 2021 - 2033)
- GI Tract
- Infectious Diseases
- Skin/Hair
- Respiratory System
- Nervous System
- Cardiovascular System
- Reproductive System
- Others
- Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
- Direct Sales
- E-sales
- Retail & Institutional Sales
- End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Hospitals & Clinics
- Home Settings
- Regional Outlook (Revenue, USD Billion, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Norway
- Sweden
- Denmark
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East & Africa (MEA)
- South Africa
- South Arabia
- UAE
- Kuwait
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Form
- 1.2.2. Application
- 1.2.3. Indications
- 1.2.4. Distribution Channel
- 1.2.5. End-use
- 1.2.6. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Volume price analysis (Model 2)
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Form outlook
- 2.2.2. Application outlook
- 2.2.3. Indications outlook
- 2.2.4. Distribution outlook
- 2.2.5. End-use outlook
- 2.3. Competitive Insights
Chapter 3. Ayurveda Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver Analysis
- 3.2.2. Market restraint analysis
- 3.3. Ayurveda Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
- 3.3.1. Industry Analysis - Porter's
Chapter 4. Ayurveda Market: Form Estimates & Trend Analysis
- 4.1. Form Market Share, 2025 to 2033
- 4.2. Segment Dashboard
- 4.3. Ayurveda Market by Form Outlook
- 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
- 4.4.1. Herbal
- 4.4.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 4.4.2. Mineral
- 4.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 4.4.3. Herbomineral
- 4.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 4.4.1. Herbal
Chapter 5. Ayurveda Market: Application Estimates & Trend Analysis
- 5.1. Application Market Share, 2025 to 2033
- 5.2. Segment Dashboard
- 5.3. Ayurveda Market by Application Outlook
- 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
- 5.4.1. Medical/Therapy
- 5.4.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 5.4.2. Personal
- 5.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 5.4.1. Medical/Therapy
Chapter 6. Ayurveda Market: Indications Estimates & Trend Analysis
- 6.1. Indications Market Share, 2025 to 2033
- 6.2. Segment Dashboard
- 6.3. Ayurveda Market by Indications Outlook
- 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
- 6.4.1. GI Tract
- 6.4.1.1. Market estimates and forecasts 2021 to 2033 (USD million)
- 6.4.2. Infectious Diseases
- 6.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 6.4.3. Skin/Hair
- 6.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 6.4.4. Respiratory System
- 6.4.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 6.4.5. Nervous System
- 6.4.5.1. Market estimates and forecasts 2021 to 2033 (USD million)
- 6.4.6. Cardiovascular System
- 6.4.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 6.4.7. Reproductive System
- 6.4.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 6.4.8. Others
- 6.4.8.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 6.4.1. GI Tract
Chapter 7. Ayurveda Market: Distribution Channel Estimates & Trend Analysis
- 7.1. Distribution Channel Market Share, 2025 to 2033
- 7.2. Segment Dashboard
- 7.3. Ayurveda Market by Distribution Channel Outlook
- 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
- 7.4.1. Direct Sales
- 7.4.1.1. Market estimates and forecasts 2021 to 2033 (USD million)
- 7.4.2. E-sales
- 7.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 7.4.3. Retail & Institutional Sales
- 7.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 7.4.1. Direct Sales
Chapter 8. Ayurveda Market: End-use Estimates & Trend Analysis
- 8.1. End-use Market Share, 2025 to 2033
- 8.2. Segment Dashboard
- 8.3. Ayurveda Market by End-use Outlook
- 8.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
- 8.4.1. Hospitals & Clinics
- 8.4.1.1. Market estimates and forecasts 2021 to 2033 (USD million)
- 8.4.2. Home Settings
- 8.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 8.4.1. Hospitals & Clinics
Chapter 9. Ayurveda Market: Regional Analysis
- 9.1. Ayurveda: Market Share Analysis, 2025 to 2033
- 9.2. Ayurveda: Market Estimates and Forecast, by Region (USD Million)
- 9.3. North America
- 9.3.1. North America Ayurveda Market, 2021 - 2033 (USD Million)
- 9.3.2. U.S.
- 9.3.2.1. U.S. dietary supplements contract manufacturing market estimates and forecasts, 2021 - 2033 (USD Million)
- 9.3.3. Canada
- 9.3.3.1. Canada Ayurveda market estimates and forecasts, 2021 - 2033 (USD Million)
- 9.3.4. Mexico
- 9.3.4.1. Mexico Ayurveda market estimates and forecasts, 2021 - 2033 (USD Million)
- 9.4. Europe
- 9.4.1. Europe Ayurveda Market, 2021 - 2033 (USD Million)
- 9.4.2. UK
- 9.4.2.1. UK Ayurveda market estimates and forecasts, 2021 - 2033 (USD Million)
- 9.4.3. Germany
- 9.4.3.1. Germany Ayurveda market estimates and forecasts, 2021 - 2033 (USD Million)
- 9.4.4. France
- 9.4.4.1. France Ayurveda market estimates and forecasts, 2021 - 2033 (USD Million)
- 9.4.5. Italy
- 9.4.5.1. Italy Ayurveda market estimates and forecasts, 2021 - 2033 (USD Million)
- 9.4.6. Spain
- 9.4.6.1. Spain Ayurveda market estimates and forecasts, 2021 - 2033 (USD Million)
- 9.4.7. Denmark
- 9.4.7.1. Denmark Ayurveda market estimates and forecasts, 2021 - 2033 (USD Million)
- 9.4.8. Sweden
- 9.4.8.1. Sweden Ayurveda market estimates and forecasts, 2021 - 2033 (USD Million)
- 9.4.9. Norway
- 9.4.9.1. Norway Ayurveda market estimates and forecasts, 2021 - 2033 (USD Million)
- 9.5. Asia Pacific
- 9.5.1. Asia Pacific Ayurveda Market, 2021 - 2033 (USD Million)
- 9.5.2. Japan
- 9.5.2.1. Japan Ayurveda market estimates and forecasts, 2021 - 2033 (USD Million)
- 9.5.3. China
- 9.5.3.1. China Ayurveda market estimates and forecasts, 2021 - 2033 (USD Million)
- 9.5.4. India
- 9.5.4.1. India Ayurveda market estimates and forecasts, 2021 - 2033 (USD Million)
- 9.5.5. Australia
- 9.5.5.1. Australia Ayurveda market estimates and forecasts, 2021 - 2033 (USD Million)
- 9.5.6. South Korea
- 9.5.6.1. South Korea Ayurveda market estimates and forecasts, 2021 - 2033 (USD Million)
- 9.5.7. Thailand
- 9.5.7.1. Thailand Ayurveda market estimates and forecasts, 2021 - 2033 (USD Million)
- 9.6. Latin America
- 9.6.1. Latin America Ayurveda Market, 2021 - 2033 (USD Million)
- 9.6.2. Brazil
- 9.6.2.1. Brazil Ayurveda market estimates and forecasts, 2021 - 2033 (USD Million)
- 9.6.3. Argentina
- 9.6.3.1. Argentina Ayurveda market estimates and forecasts, 2021 - 2033 (USD Million)
- 9.7. MEA
- 9.7.1. MEA Ayurveda Market, 2021 - 2033 (USD Million)
- 9.7.2. South Africa
- 9.7.2.1. South Africa Ayurveda market estimates and forecasts, 2021 - 2033 (USD Million)
- 9.7.3. Saudi Arabia
- 9.7.3.1. Saudi Arabia Ayurveda market estimates and forecasts, 2021 - 2033 (USD Million)
- 9.7.4. UAE
- 9.7.4.1. UAE Ayurveda market estimates and forecasts, 2021 - 2033 (USD Million)
- 9.7.5. Kuwait
- 9.7.5.1. Kuwait Ayurveda market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 10. Competitive Landscape
- 10.1. Recent Developments & Impact Analysis, By Key Market Participants
- 10.2. Company/Competition Categorization
- 10.3. Vendor Landscape
- 10.3.1. List of key distributors and channel partners
- 10.3.2. Key customers
- 10.3.3. Key company heat map analysis, 2025
- 10.4. Company Profiles
- 10.4.1. Kerala Ayurveda Ltd.
- 10.4.1.1. Company overview
- 10.4.1.2. Financial performance
- 10.4.1.3. Product benchmarking
- 10.4.1.4. Strategic initiatives
- 10.4.2. Patanjali Ayurved Limited
- 10.4.2.1. Company overview
- 10.4.2.2. Financial performance
- 10.4.2.3. Product benchmarking
- 10.4.2.4. Strategic initiatives
- 10.4.3. Dabur Ltd.
- 10.4.3.1. Company overview
- 10.4.3.2. Financial performance
- 10.4.3.3. Product benchmarking
- 10.4.3.4. Strategic initiatives
- 10.4.4. Natreon Inc.
- 10.4.4.1. Company overview
- 10.4.4.2. Financial performance
- 10.4.4.3. Product benchmarking
- 10.4.4.4. Strategic initiatives
- 10.4.5. Vicco Laboratories
- 10.4.5.1. Company overview
- 10.4.5.2. Financial performance
- 10.4.5.3. Product benchmarking
- 10.4.5.4. Strategic initiatives
- 10.4.6. Himalaya Wellness Company
- 10.4.6.1. Company overview
- 10.4.6.2. Financial performance
- 10.4.6.3. Product benchmarking
- 10.4.6.4. Strategic initiatives
- 10.4.7. Emami Group of Companies Pvt Ltd.
- 10.4.7.1. Company overview
- 10.4.7.2. Financial performance
- 10.4.7.3. Product benchmarking
- 10.4.7.4. Strategic initiatives
- 10.4.8. Bio Veda Action Research Co.
- 10.4.8.1. Company overview
- 10.4.8.2. Financial performance
- 10.4.8.3. Product benchmarking
- 10.4.8.4. Strategic initiatives
- 10.4.9. Amrutanjan Health Care Limited
- 10.4.9.1. Company overview
- 10.4.9.2. Financial performance
- 10.4.9.3. Product benchmarking
- 10.4.9.4. Strategic initiatives
- 10.4.10. Baidyanath
- 10.4.10.1. Company overview
- 10.4.10.2. Financial performance
- 10.4.10.3. Product benchmarking
- 10.4.10.4. Strategic initiatives
- 10.4.1. Kerala Ayurveda Ltd.
